within Pharmacolibrary.Drugs.ATC.N;

model N03AC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.0008333333333333334,
    adminDuration  = 600,
    adminMass      = 900 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.001,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N03AC02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Trimethadione is an anticonvulsant medication from the oxazolidinedione class, primarily used in the past for the treatment of absence (petit mal) seizures. Due to its side effect profile and the availability of safer alternatives, its use is now largely historical, and the drug is rarely prescribed in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients (normal renal and hepatic function) after oral administration.</p><h4>References</h4><ol><li><p>Tanaka, E, Yoshida, T, &amp; Kuroiwa, Y (1985). Dose-independent pharmacokinetics of trimethadione and its metabolite in rats. <i>Journal of pharmaceutical sciences</i> 74(3) 340–341. DOI:<a href=\"https://doi.org/10.1002/jps.2600740326\">10.1002/jps.2600740326</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4009447/\">https://pubmed.ncbi.nlm.nih.gov/4009447</a></p></li><li><p>Nau, H (1986). Species differences in pharmacokinetics and drug teratogenesis. <i>Environmental health perspectives</i> 70 113–129. DOI:<a href=\"https://doi.org/10.1289/ehp.8670113\">10.1289/ehp.8670113</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3104022/\">https://pubmed.ncbi.nlm.nih.gov/3104022</a></p></li><li><p>Tanaka, E, Ishikawa, A, Abei, M, &amp; Kobayashi, S (1996). Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans. <i>Comparative biochemistry and physiology. Part C, Pharmacology, toxicology &amp; endocrinology</i> 115(3) 211–216. DOI:<a href=\"https://doi.org/10.1016/s0742-8413(96)00102-8\">10.1016/s0742-8413(96)00102-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9375358/\">https://pubmed.ncbi.nlm.nih.gov/9375358</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N03AC02;
